Project Grant 1L1CMS331463

The University of Rochester was awarded a 5-year, $223,364 Project Grant from the National Center for Advancing Translational Sciences (NCATS), CFDA 93.350, to operate a Clinical and Translational Science Institute (CTSI) pre-doctoral training program. The program aims to cultivate the next generation of leaders in translational science research by providing a comprehensive mentored research experience, transdisciplinary educational opportunities, career development planning, and a supportive...

The U.S. Department of Health and Human Services, through the Primary Care Training and Enhancement (PCTE) Program (CFDA 93.884), awarded a $500,000 project grant to Valley Health Team, Inc., a federally qualified health center in California. The grant funds will support the development and implementation of a comprehensive 36-month street medicine curriculum within the organization's family medicine residency program. Key objectives include enhancing residents' competencies in treating...

The National Institutes of Health's National Center for Advancing Translational Sciences (NCATS) awarded a $8,372,910 Cooperative Agreement to the State University of New York at Buffalo's Clinical and Translational Science Institute (CTSI) on January 6, 2025. The CTSI, in partnership with the Buffalo Translational Consortium, is implementing translational science strategies to reduce health inequities and improve health in the Buffalo, NY region through 2031. Key objectives include increasing...

The National Institutes of Health's National Center for Advancing Translational Sciences (NCATS) awarded a $456,728 Project Grant to Case Western Reserve University (CWRU) on July 8, 2025. The grant supports the CWRU Predoctoral Clinical and Translational Scientist Training Program (CTSTP-PRE), which aims to train the next generation of clinical and translational scientists. The program provides Ph.D., MD-Ph.D., and DNP-Ph.D. students with transdisciplinary skills to advance clinical and...

This Project Grant award of $294,186 from the National Center for Advancing Translational Sciences (NCATS), CFDA 93.350, supports the "CTSA PREDOCTORAL T32 AT THE UNIVERSITY OF FLORIDA: CTS TEAM TRAINING" program at the University of Florida. The program aims to develop and implement a unique clinical and translational research training program for pairs of PhD and/or combined degree (e.g., MD-PhD) trainees across different disciplines and colleges. The trainees will collaborate on...

This $499,956 Primary Care Training and Enhancement (PCTE) grant award from the Health Resources and Services Administration (HRSA) - CFDA 93.884 aims to enhance the training of family medicine residents, faculty, and other primary care providers in delivering comprehensive, evidence-based care to individuals experiencing homelessness in Pawtucket, Rhode Island. The key objectives of the initiative are to: 1) prepare primary care providers to address the complex healthcare needs of the...

This Project Grant award from the Health Resources and Services Administration (HRSA), under the Primary Care Training and Enhancement (PCTE) program (CFDA 93.884), will provide $2,439,093 over 5 years to East Tennessee State University (ETSU) to develop and implement an interprofessional, team-based street medicine curriculum for its family medicine residency programs. The project, "Taking to the Streets: Building Bridges to Healthcare for the Unhoused," will train 140 residents in...

This federal Project Grant award of $237,032, provided by the National Center for Advancing Translational Sciences (NCATS) under the CTSA PREDOCTORAL T32 PROGRAM (CFDA 93.350), supports a 2-year comprehensive training program in clinical and translational science at the Medical University of South Carolina (MUSC). The program aims to train a multidisciplinary group of 4 predoctoral trainees at a time to become skilled translational scientists capable of applying clinical and translational...

This National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) Project Grant award of $285,444, effective August 15, 2025 through August 14, 2026 (CFDA 93.350), aims to develop recombinant human enzyme panels representing genetic variants of drug-metabolizing enzymes present in the U.S. patient population. The goal is to bridge shortcomings in current in vitro drug metabolism testing, which typically relies on liver microsomes or hepatocytes from...

The University of Chicago received a $1,383,791 Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) to integrate a pharmacy technician-based model for delivering long-acting injectable cabotegravir-rilpivirine (LA-CAB/RPV) HIV treatment into community-based Federally Qualified Health Centers (FQHCs) that serve underserved people living with HIV. The overarching goal is to adapt and test this model in five FQHC clinics in Chicago,...